Covington Capital Management’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $32K | Hold |
495
| – | – | ﹤0.01% | 628 |
|
|
2022
Q2 | $30K | Buy |
495
+100
| +25% | +$6.06K | ﹤0.01% | 639 |
|
|
2022
Q1 | $25K | Hold |
395
| – | – | ﹤0.01% | 682 |
|
|
2021
Q4 | $30K | Hold |
395
| – | – | ﹤0.01% | 611 |
|
|
2021
Q3 | $44K | Hold |
395
| – | – | ﹤0.01% | 565 |
|
|
2021
Q2 | $64K | Hold |
395
| – | – | ﹤0.01% | 506 |
|
|
2021
Q1 | $48K | Hold |
395
| – | – | ﹤0.01% | 482 |
|
|
2020
Q4 | $60K | Hold |
395
| – | – | ﹤0.01% | 441 |
|
|
2020
Q3 | $33K | Hold |
395
| – | – | ﹤0.01% | 482 |
|
|
2020
Q2 | $29K | Buy |
395
+20
| +5% | +$1.47K | ﹤0.01% | 495 |
|
|
2020
Q1 | $16K | Sell |
375
-200
| -35% | -$8.53K | ﹤0.01% | 552 |
|
|
2019
Q4 | $35K | Hold |
575
| – | – | ﹤0.01% | 513 |
|
|
2019
Q3 | $24K | Hold |
575
| – | – | ﹤0.01% | 530 |
|
|
2019
Q2 | $27K | Hold |
575
| – | – | ﹤0.01% | 508 |
|
|
2019
Q1 | $21K | Hold |
575
| – | – | ﹤0.01% | 529 |
|
|
2018
Q4 | $16K | Hold |
575
| – | – | ﹤0.01% | 574 |
|
|
2018
Q3 | $26K | Buy |
575
+200
| +53% | +$9.04K | ﹤0.01% | 500 |
|
|
2018
Q2 | $22K | Hold |
375
| – | – | ﹤0.01% | 535 |
|
|
2018
Q1 | $17K | Buy |
375
+175
| +88% | +$7.93K | ﹤0.01% | 577 |
|
|
2017
Q4 | $5K | Hold |
200
| – | – | ﹤0.01% | 742 |
|
|
2017
Q3 | $4K | Buy |
+200
| New | +$4K | ﹤0.01% | 661 |
|